Drug repositioning: identifying and developing new uses for existing drugs

@article{Ashburn2004DrugRI,
  title={Drug repositioning: identifying and developing new uses for existing drugs},
  author={T. T. Ashburn and K. Thor},
  journal={Nature Reviews Drug Discovery},
  year={2004},
  volume={3},
  pages={673-683}
}
Biopharmaceutical companies attempting to increase productivity through novel discovery technologies have fallen short of achieving the desired results. Repositioning existing drugs for new indications could deliver the productivity increases that the industry needs while shifting the locus of production to biotechnology companies. More and more companies are scanning the existing pharmacopoeia for repositioning candidates, and the number of repositioning success stories is increasing. 
1,751 Citations
Drug Repositioning: A Faster Path to Drug Discovery
Mining small-molecule screens to repurpose drugs
Drug repositioning by structure-based virtual screening.
New drugs are not enough-drug repositioning in oncology: An update
Medicinal chemistry strategies in follow-on drug discovery.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 69 REFERENCES
A guide to drug discovery: Trends in development and approval times for new therapeutics in the United States
  • J. Reichert
  • Political Science, Medicine
  • Nature Reviews Drug Discovery
  • 2003
New ways to take old drugs.
Colonizing therapeutic space: the overlooked science of drug husbandry
  • Medicine
  • Nature Reviews Drug Discovery
  • 2004
Thalidomide is an inhibitor of angiogenesis.
Moving beyond the genome projects
...
1
2
3
4
5
...